Juliet Holt Klinger, MA, Expert on Dementia Care

Contact Juliet
16 June 2021

Brookdale's Senior Director of Dementia Care, Juliet Holt Klinger, shares insight into the recently approved use of Aduhelm, the drug marketed to slow progression of the brain disease, in a new blog on brookdale.com. 

The advancement in treatment is reason for hope, and Juliet is "cautiously optimistic."  

The blog, titled, FDA Approval of New Alzheimer's Drug Offers Hope provides information about the drug, quotes from Juliet regarding the advancement and links to both the FDA and Alzheimer's Association news. 

Like what you read?

Click here to sign up for news alerts.

Share on Social Media